286 related articles for article (PubMed ID: 18416599)
1. Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma.
Kelly KA; Bardeesy N; Anbazhagan R; Gurumurthy S; Berger J; Alencar H; Depinho RA; Mahmood U; Weissleder R
PLoS Med; 2008 Apr; 5(4):e85. PubMed ID: 18416599
[TBL] [Abstract][Full Text] [Related]
2. Optical magnetic multimodality imaging of plectin-1-targeted imaging agent for the precise detection of orthotopic pancreatic ductal adenocarcinoma in mice.
Zhang W; Liang X; Zhu L; Zhang X; Jin Z; Du Y; Tian J; Xue H
EBioMedicine; 2022 Jun; 80():104040. PubMed ID: 35525203
[TBL] [Abstract][Full Text] [Related]
3. A novel plectin/integrin-targeted bispecific molecular probe for magnetic resonance/near-infrared imaging of pancreatic cancer.
Wang Q; Yan H; Jin Y; Wang Z; Huang W; Qiu J; Kang F; Wang K; Zhao X; Tian J
Biomaterials; 2018 Nov; 183():173-184. PubMed ID: 30172243
[TBL] [Abstract][Full Text] [Related]
4. Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1.
Foygel K; Wang H; Machtaler S; Lutz AM; Chen R; Pysz M; Lowe AW; Tian L; Carrigan T; Brentnall TA; Willmann JK
Gastroenterology; 2013 Oct; 145(4):885-894.e3. PubMed ID: 23791701
[TBL] [Abstract][Full Text] [Related]
5. Plectin-1 Targeted Dual-modality Nanoparticles for Pancreatic Cancer Imaging.
Chen X; Zhou H; Li X; Duan N; Hu S; Liu Y; Yue Y; Song L; Zhang Y; Li D; Wang Z
EBioMedicine; 2018 Apr; 30():129-137. PubMed ID: 29574092
[TBL] [Abstract][Full Text] [Related]
6. Plectin-1 as a novel biomarker for pancreatic cancer.
Bausch D; Thomas S; Mino-Kenudson M; Fernández-del CC; Bauer TW; Williams M; Warshaw AL; Thayer SP; Kelly KA
Clin Cancer Res; 2011 Jan; 17(2):302-9. PubMed ID: 21098698
[TBL] [Abstract][Full Text] [Related]
7. Targeting pancreatic ductal adenocarcinoma acidic microenvironment.
Cruz-Monserrate Z; Roland CL; Deng D; Arumugam T; Moshnikova A; Andreev OA; Reshetnyak YK; Logsdon CD
Sci Rep; 2014 Mar; 4():4410. PubMed ID: 24642931
[TBL] [Abstract][Full Text] [Related]
8. Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin.
Chen W; Zhou Y; Zhi X; Ma T; Liu H; Chen BW; Zheng X; Xie S; Zhao B; Feng X; Dang X; Liang T
Biomaterials; 2019 Feb; 192():590-600. PubMed ID: 30553134
[TBL] [Abstract][Full Text] [Related]
9. DOTA-Based Plectin-1 Targeted Contrast Agent Enables Detection of Pancreatic Cancer in Human Tissue.
Gazzi T; Lesina M; Wang Q; Berninger A; Radetzki S; Demir IE; Kohlmann L; Meiser W; Wilke S; von Kries JP; Algül H; Hu HY; Nazare M
Angew Chem Int Ed Engl; 2024 Jun; 63(26):e202318485. PubMed ID: 38608197
[TBL] [Abstract][Full Text] [Related]
10. Multifaceted peptide assisted one-pot synthesis of gold nanoparticles for plectin-1 targeted gemcitabine delivery in pancreatic cancer.
Pal K; Al-Suraih F; Gonzalez-Rodriguez R; Dutta SK; Wang E; Kwak HS; Caulfield TR; Coffer JL; Bhattacharya S
Nanoscale; 2017 Oct; 9(40):15622-15634. PubMed ID: 28991294
[TBL] [Abstract][Full Text] [Related]
11. Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models.
Cruz-Monserrate Z; Abd-Elgaliel WR; Grote T; Deng D; Ji B; Arumugam T; Wang H; Tung CH; Logsdon CD
Gut; 2012 Sep; 61(9):1315-22. PubMed ID: 22068166
[TBL] [Abstract][Full Text] [Related]
12. Unexpected gain of function for the scaffolding protein plectin due to mislocalization in pancreatic cancer.
Shin SJ; Smith JA; Rezniczek GA; Pan S; Chen R; Brentnall TA; Wiche G; Kelly KA
Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19414-9. PubMed ID: 24218614
[TBL] [Abstract][Full Text] [Related]
13. Chimeric peptide supramolecular nanoparticles for plectin-1 targeted miRNA-9 delivery in pancreatic cancer.
Wu Y; Tang Y; Xie S; Zheng X; Zhang S; Mao J; Wang B; Hou Y; Hu L; Chai K; Chen W
Theranostics; 2020; 10(3):1151-1165. PubMed ID: 31938057
[TBL] [Abstract][Full Text] [Related]
14. Plectin-1 Targeted AAV Vector for the Molecular Imaging of Pancreatic Cancer.
Konkalmatt PR; Deng D; Thomas S; Wu MT; Logsdon CD; French BA; Kelly KA
Front Oncol; 2013; 3():84. PubMed ID: 23616947
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a radioiodinated peptide probe targeting αvβ6 integrin for the detection of pancreatic ductal adenocarcinoma.
Ueda M; Fukushima T; Ogawa K; Kimura H; Ono M; Yamaguchi T; Ikehara Y; Saji H
Biochem Biophys Res Commun; 2014 Mar; 445(3):661-6. PubMed ID: 24583127
[TBL] [Abstract][Full Text] [Related]
17. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
[TBL] [Abstract][Full Text] [Related]
18. Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.
Laeseke PF; Chen R; Jeffrey RB; Brentnall TA; Willmann JK
Radiology; 2015 Dec; 277(3):644-61. PubMed ID: 26599925
[TBL] [Abstract][Full Text] [Related]
19. A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma.
Sahni S; Pandya AR; Hadden WJ; Nahm CB; Maloney S; Cook V; Toft JA; Wilkinson-White L; Gill AJ; Samra JS; Dona A; Mittal A
Int J Cancer; 2021 Mar; 148(6):1508-1518. PubMed ID: 33128797
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]